Sionna Therapeutics, Inc.(SION)
$3.33-0.10 (-2.92%)
SION
Sionna Therapeutics, Inc. stock forecast
$3.33
At close:-0.10 (-2.92%)
Want to see SION full AI Analyst Report?
Sionna Therapeutics, Inc. (SION) Stock Forecast & Price Target
71 Followers
SION Analyst Ratings
Hold
1Buy6Hold0Sell
Based on 7 analysts giving stock ratings to Sionna Therapeutics, Inc. in the past 3 months
SION Stock 12 Month Forecast
Average Price Target
$6.00▲(80.18% Upside)Based on 7 Wall Street analysts offering 12 month price targets for Sionna Therapeutics, Inc. in the last 3 months. The average price target is $6.00 with a high forecast of $7.00 and a low forecast of $5.00. The average price target represents a 80.18% change from the last price of $3.33.
Past 12 Months12 Month ForecastJan2026Oct2026
High$7.00
Average$6.00
Low$5.00
Highest Price TargetHighest$7.00Average Price Target$6.00Lowest Price TargetLowest$5.00
Detailed List of Analyst Forecasts
Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
| Price Target | Article | |||||||
|---|---|---|---|---|---|---|---|---|
| Ritu Baral | TD Cowen | ― | buy | ― | Reiterated | 11/11/26 | ||
| Kambiz Yazdi | BTIG | ― | hold | ― | Reiterated | 11/10/26 | ||
| Brian Abrahams | RBC Capital | $5 | hold | 50.15%Upside | Reiterated | 11/10/26 | ||
| Gaurav Maini | LifeSci Capital | $6 | hold | 80.18%Upside | Reiterated | 09/19/26 | ||
| Paul Matteis | Stifel Nicolaus | $7 | hold | 110.21%Upside | Reiterated | 09/15/26 | ||
| Laura Chico | Wedbush | $5→$6 | hold | 80.18%Upside | Reiterated | 09/15/26 | ||
| Yatin Suneja | Guggenheim | ― | hold | ― | Reiterated | 09/15/26 | ||
| Ilya Zubkov | Freedom Capital Markets | $38→$5 | hold | 50.15%Upside | Reiterated | 08/11/26 | ||
| Debanjana Chatterjee | JonesTrading | $63 | hold | 1791.89%Upside | Downgraded | 08/10/26 | ||
| Christopher Raymond | Raymond James | ― | hold | ― | Downgraded | 08/10/26 | ||
| Jonathan Wolleben | Citizens JMP | ― | hold | ― | Downgraded | 08/10/26 |
| Rating | Article | ||||
|---|---|---|---|---|---|
| Ritu BaralTD Cowen | BuyReiterated | 11/11/26 | ― | ||
| Kambiz YazdiBTIG | HoldReiterated | 11/10/26 | ― | ||
| Brian AbrahamsRBC Capital | HoldReiterated$5 | 11/10/26 | 50.15%Upside | ||
| Gaurav MainiLifeSci Capital | HoldReiterated$6 | 09/19/26 | 80.18%Upside | ||
| Paul MatteisStifel Nicolaus | HoldReiterated$7 | 09/15/26 | 110.21%Upside | ||
| Laura ChicoWedbush | HoldReiterated$5→$6 | 09/15/26 | 80.18%Upside | ||
| Yatin SunejaGuggenheim | HoldReiterated | 09/15/26 | ― | ||
| Ilya ZubkovFreedom Capital Markets | HoldReiterated$38→$5 | 08/11/26 | 50.15%Upside | ||
| Debanjana ChatterjeeJonesTrading | HoldDowngraded$63 | 08/10/26 | 1791.89%Upside | ||
| Christopher RaymondRaymond James | HoldDowngraded | 08/10/26 | ― | ||
| Jonathan WollebenCitizens JMP | HoldDowngraded | 08/10/26 | ― |
Stocks with the Highest Top Analyst Consensus in the General Sector
Best Analysts Covering Sionna Therapeutics, Inc.
3 Months
Success Rate6/8 ratings generated profit
75%
Average Return
+7.64%
Copying Ritu Baral's trades and holding each position for 3 Months would result in 75.00% of your transactions generating a profit, with an average return of +7.64% per trade.
1 Year
Success Rate3/8 ratings generated profit
38%
Average Return
+27.16%
Copying Ritu Baral's trades and holding each position for 1 Year would result in 37.50% of your transactions generating a profit, with an average return of +27.16% per trade.
2 Years
Success Rate0/8 ratings generated profit
0%
Average Return
-83.03%
Copying Ritu Baral's trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -83.03% per trade.
SION Analyst Recommendation Trends
| Rating | Jul 26 | Aug 26 | Sep 26 | Oct 26 | Nov 26 |
|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 0 | 0 | 0 |
| Buy | 16 | 7 | 5 | 3 | 1 |
| Hold | 1 | 10 | 15 | 15 | 7 |
| Sell | 1 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 1 | 1 | 1 | 0 |
| total | 21 | 21 | 21 | 19 | 8 |
In the current month, SION has received 1 Buy Ratings, 7 Hold Ratings, and 0 Sell Ratings. SION average Analyst price target in the past 3 months is 6.00.
SION Financial Forecast
High$-0.43
Consensus$-0.58
Low$-0.73
SION Earnings Forecast
Next quarter’s earnings estimate for SION is -$0.58 with a range of -$0.73 to -$0.43. The previous quarter’s EPS was -$0.72. Its overall industry beat the EPS estimate 50.49% of the time in the past 12 months.
High$0.00
Consensus$0.00
Low$0.00
SION Sales Forecast
Next quarter’s sales forecast for SION is $0 with a range of $0 to $0. The previous quarter’s sales results were $0. Its overall industry beat sales estimates 63.25% of the time in the past 12 months.
SION Stock Forecast FAQ
What is SION’s average 12-month price target, according to analysts?
Based on analyst ratings, Sionna Therapeutics, Inc.’s 12-month average price target is $6.00.
What is SION’s upside potential, based on the analysts’ average price target?
Sionna Therapeutics, Inc. has 80.18% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is SION a Buy, Sell or Hold?
Sionna Therapeutics, Inc. has a consensus rating of Hold which is based on 1 buy ratings, 6 hold ratings and 0 sell ratings.
What is Sionna Therapeutics, Inc.’s price target?
The average price target for Sionna Therapeutics, Inc. is $6.00. This is based on 7 12-month price targets, issued in the past 3 months. The highest analyst price target is $7.00, the lowest forecast is $5.00. The average price target represents a 80.18% increase from the current price of $3.33.
What do analysts say about Sionna Therapeutics, Inc.?
Sionna Therapeutics, Inc.’s analyst rating consensus is a Hold. This is based on the ratings of 7 Wall Street analysts.
How can I buy shares of SION?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
